Sanara Medtech Inc. · NASDAQ:SMTI
Sanara Medtech — Wound Management Technologies — Investor Presentation (May 2010)
19 slides from Sanara Medtech's investor presentation, May 6, 2010
Slide 1: Wound Management Technologies: Changing the paradigm in wound healing
| Wound Management cy TECHNOLOGIES, INC. Changing the paradigm in wound healing management and eHealth solutions - Philip J. Rubinfeld, MD, FIPP
Slide 2: Safe Harbor Statement
Safe Harbor Statement Statements in this Presentation are made as of the date of this Presentation unless stated otherwise and are subject to change, completion, or amendment without notice. Neither the delivery of this Presentation at any time shall under any circumstances create an implication tha
Slide 3: Wound Management Markets
Wound Management Markets Wound Management’s unique patented CellerateRX® products address the very large and growing advanced wound care markets. » U.S. market in 2007 was $3.0B and is projected to double by 2013 Total U.S. Advanced Wound Care Market $ Millions Copyright © 2010 Wound Management Tech
Slide 4: Diabetes — A Worldwide Epidemic, a Prime Market for CellerateRX
Diabetes — A Worldwide Epidemic, a Prime Market for CellerateRX \ According to the IDF, approximately 285M people will live with /™~ diabetes in 2010. WHO projects this to grow to 360M by 2030 \' Diabetes affects approximately 24M Americans; 57M are pre- diabetic and likely to develop diabetes withi
Slide 5: Financial Highlights & Projections
Financial Highlights & Projections 14,000,000 - 12,000,000 = 10,000,000 8,000,000 —— 6,000,000 4,000,000 2,000,000 0 -2,000,000 ~4,000,000 Revenue Net Income 2009 2010e 2011e [Revenue | 288,021 4,788,125 | 12,021,250 Net Income) (2,302,527) | 2,315,547 6,752,877 Copyright © 2010 Wound Management Tec
Slide 6: Sales Team in Place
Sales Team in Place > Poised for Growth: having completed evidence- based studies , Wound Management developed its sales channel plan and engaged sales and marketing executives in April 2010. > Growth from: — Growing brand recognition — 4new direct reps in Florida — Management of independent rep cha
Slide 7: CellerateRX International Sales
CellerateRX International Sales > Sales: Middle East Distribution in Place > Lebanon (1Q 2010) » Pending Sales: Saudi Arabia, Iran, Dubai, Qatar, Bahamas > European Distribution Agreement in Place: Biocure S.r.I. of Milan, Italy )/ » Registration in process: Columbia, Mexico > Distribution initiativ
Slide 8: Why CellerateRX?
Why CellerateRX? > CellerateRX® is available in powder and gel forms > Itis a unique, patented, activated collagen that delivers immediate benefits to the wound > Cost-effective » Both product cost and labor involved » Biocompatible and biodegradable » Unprecedented range of use in every wound phase
Slide 9: Regulatory Status
Regulatory Status » Reimbursed by Medicare Part B » Regulated as a medical device > CellerateRX® does not require a prescription >» FDA cleared for all wounds* including: Pressure Ulcers (stage | - IV) Diabetic Ulcers Venous Stasis Ulcers Traumatic Wounds Surgical Wounds 4&2" Degree Bums Uleers due
Slide 10: Help for All Ages
Help for All Ages Leona Lake — 99 years old this month. In 2009 she was seeking help to heal a bad wound from radiation _ treatment. She went months with no positive results from other products and had to stop her pool exercise. After 5 weeks of using CellerateRX, the wound healed completely and she
Slide 11: Biotech Pipeline
Biotech Pipeline Resorbable Bone Wax & Bone Void Filler products > $1.4B Worldwide Bio Materials Market » Resorbable orthopedic hemostat used to stop blood flow & delivery system for osteogenic / osteoinductive orthopedic products > Less than $100k to finalize products to market, filing of 510k » Sy
Slide 12: Secure eHealth: Emerging Now
Secure Emerging Now eHealth.- Implementing plan to become a leading provider of secure communications solutions across all segments of the healthcare industry. > Perfect Opportunity: > Pressure continues to mount towards collaborative healthcare that requires “secure” communication > Billions being
Slide 13: Secure eHealth suite of products
Secure Health.. Acomplete suite of scalable products for secure, intelligent healthcare communication, collaboration, storage and transport >» HIPAA/ARRA compliant »>Cross platform compatible, | including handheld devices | for complete mobility > Simple integration with present systems Copyright ©
Slide 14: Secure eHealth target markets and advantages
Secure S eHealth.. > Target Markets we + Health Plans > Distinct Advantages + Existing partnerships + Scalable technology * Open integration + Health Information Exchanges + Disease Management Organizations + Clinical Trial Recruitment Copyright © 2010 Wound Management Technolgies nc.
Slide 15: Secure eHealth projects and partners
Secure Health.. > HealthPoints Inc. — Diabetic Disease Management Project » Remote monitoring & management of diabetic patients in Metro Dallas area > GSI Health, Inc. — Collaborative security infrastructure for HIE, HIN, RHIO projects > Private Access, Inc. — Licensee of Envoii secure notification
Slide 16: Management
Management > Scott Haire, Chairman/CEO, has extensive experience in eHealth management systems. Prior to Wound Management, he was President of Preferred Payment Systems. >» Deborah Jenkins Hutchinson, President, has over 30 years of experience in both healthcare and technology sectors with a success
Slide 17: Management, continued
Management, continued > Robert Tapales, President of Secure eHealth, LLC Division. Robert has over 20 years in health management experience having previously served as EVP and COO for several healthcare technology companies, and most recently as EVP for VirtualHealth Technologies, Inc. > Barry Const
Slide 18: Stock Overview
Stock Overview Wound Management Technology, Inc. (WNDM) is a rapidly growing provider of advanced biotechnology products and eHealth technology solutions. = Symbol: WNDM = Exchange: OTC BB = Shares Outstanding: 34,748,160 a = Estimated Float: 3.3M | = Last Trade: $0.90 = 52-Week range: $.70 - $3.25
Slide 19: Wound Management Technologies contact details
AY | Wound Management QS J TECHNOLOGIES, INC. 777 Main Street, Suite 3100 Fort Worth, Texas 76102 USA +1 (817) 820-7080 www.wmgtech.com | www.celleraterx.com www.secureehealth.com Deborah Jenkins Hutchinson djenkins@wmgtech.com Copyright © 2010 Wound Management Technolgies nc.
Wound Management Technologies — Investor Presentation (May 2010) on 6ix